Results on SARS-CoV-2 mRNA Vaccine Booster from an Open-Label Multicenter Study in Ofatumumab-Treated Participants with Relapsing Multiple Sclerosis - Ziemssen, T; Schlegel, E; Groth, M (Vaccines (Basel), 2023)